Acumen Pharmaceuticals, Inc. (ABOS) stock
ABOSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.23+0.01 (+6.53%)
Close on Nov 17, 2026Market cap $16.64MP/E –Yield –
Acumen Pharmaceuticals total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Acumen Pharmaceuticals's total debt was $20.40M at Sep 30, 2026. For fiscal 2025 it was $8.77M.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.77M | – |
| FY2024 | Dec 31, 2024 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $20.40M | +467.1% |
| Q2 FY2026 | Jun 30, 2026 | $19.67M | – |
| Q1 FY2026 | Mar 31, 2026 | $14.12M | – |
| Q4 FY2025 | Dec 31, 2025 | $8.77M | – |
| Q3 FY2025 | Sep 30, 2025 | $3.60M | – |
| Q4 FY2024 | Dec 31, 2024 | $0 | – |
See a number that looks wrong?